FDA Biologics (BLA & Biosimilars)Original article
Expedited IND Rolling Submission Process and Program Structure
RegulatoryNeutral
AI Analysis
Summary
An FDA Biologics page describes the Expedited IND Pilot's rolling submission process, noting that most of the pilot occurs in the Pre-IND phase of nonclinical development before a sponsor submits the official 30-day IND application.
Importance:3/10
Sentiment:
0.10
FDAExpedited IND PilotPre-INDregulatory processIND rolling submission
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on October 16, 2026 7:28 PM